Cell Therapeutics, Inc. (NASDAQ:CTIC)

Top Analyst Upgrades and Downgrades: Albermarle, Allergan, Boston Scientific, eBay, FedEx, Gogo, LendingTree, Nokia, UPS, Vertex and More

The stock market has demonstrated that perhaps the return of volatility is real after Wednesday's big gains suddenly turned into a big loss in the final 30 minutes of trading. ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alcoa, ADM, Citigroup, Gap, Kroger, Nike, Nucor, Rite Aid, Teva, Under Armour and More

Stocks were indicated to open higher again on Tuesday after strong gains on Monday. Investors should keep in mind that the major stock indexes still remain close to all-time highs. Another ...
Read Full Story »
biotech word cloud

4 BioPharma Movers That Cannot Be Ignored

Over the past week, a few biotech companies made absolutely massive runs, either up and down. In the past year, the health care sector was on fire from positive trials, ...
Read Full Story »
clinical trials

CTI BioPharma Stumbles Over Full Clinical Hold

CTI BioPharma Corp. (NASDAQ: CTIC) has practically become a penny stock overnight following an update from its Investigational New Drug (IND) application for pacritinib. The update basically states that the ...
Read Full Story »
ThinkstockPhotos-475472230

Top Analyst Upgrades and Downgrades: Akamai, BBVA, Dean Foods, SolarCity, Valero and Many More

Stocks got a big boost on news that Janet Yellen is talking down the Federal Reserve's desire to hike interest rates no matter what. Investors in 2016 have used rallies ...
Read Full Story »
buy sell

6 Analyst Stock Picks Called to Rise 50% to 100%

Is the bull market ready to take a breather after more than six years? That is what seven days of negative Dow Jones Industrial Average performance will make investors wonder. ...
Read Full Story »
Biotechnology word cloud

How 6 ASCO Biotech Winners Are Focusing on the Future of Cancer

The American Society of Clinical Oncology (ASCO) had its annual meeting this past week. In this meeting, companies and cancer drug developers shared results from their most recent drug trials. ...
Read Full Story »
ten dollar bills

9 Analyst Stock Picks Under $10 With Massive Upside Calls

With the bull market now six years old and with a Federal Reserve expected to finally begin raising interest rates in the months ahead, investors get jittery any time there ...
Read Full Story »
health care

6 Key Cancer Winners From ASCO Presentations

The American Society of Clinical Oncology, or ASCO, is currently having its annual meeting, in which companies and cancer drug developers share results from their most recent drug trials. The ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Ambev, CTI Bio, Duke, Humana, Occidental, Yelp and More

Stocks were indicated higher on Monday after last week's selling. The culprit is a market rumor that Greece may reach a debt pact today, which maybe everyone should only believe ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Abercrombie, Broadcom, Keurig, NOV, Transocean, Weatherford and More

Stocks were indicated lower on Friday morning ahead of a GDP revision. While this week has been a pullback, the reality is that investors have lined up for close to ...
Read Full Story »
ten bucks

Thirteen Analyst Stocks Under $10 With Big Upside Calls

Stocks are still challenging all-time highs, and investors keep hearing that the bull market has now become a stock picker's market. What this means is that investors still will try ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, BP, Gap, Teva and More

This week marks the beginning of the end for earnings season, and both the Dow Jones Industrial Average and S&P 500 hit new all-time highs last week. Now investors and traders ...
Read Full Story »
Bull and Bear figures

24/7 Wall St. Closing Bell — March 1, 2013: Markets Struggle to Small Gains (DB, V, DRI, BUD, ADSK, BODY, CTIC, CLNE, DECK, GPS, MCP, PANW, SD, BBY, ARNA, BYD, SSYS, RIG, GRPN, MTG, IEP)

U.S. equity markets opened lower this morning following a number of disappointing data releases in Europe and Asia. Eurozone PMI remains on the pessimistic side, with a reading of 47.9, ...
Read Full Story »
Bull and Bear figures

24/7 Wall St. Closing Bell — February 28, 2013: Markets Climb Before Late Day Slide (EBAY, RHT, SKS, FSLR, VMW, CECO, CLR, GRPN, GTAT, JCP, LTD, MNST, RGR, PANL, BKS, CVC, KSS, SHLD, BODY, CTIC, CLNE, DECK, GPS, MCP, PANW, SD, BBY, GRPN, JCP, BSFT)

U.S. equity markets opened mixed this morning as the federal budget sequester appears to be set to go into effect tomorrow. Global data releases were also mixed. In Europe, the ...
Read Full Story »